Answer
Licensing depends on formulation. The selected nasal spray is licensed from age 12, but selected oral formulations are not recommended for under-18s because efficacy has not been established.
Sources for this answer
- Zolmitriptan 2.5 mg Orodispersible Tablets — Current selected SmPCemc · Summary of Product Characteristics
- Zolmitriptan Grunenthal 5 mg Nasal Spray — Current selected SmPCemc · Summary of Product Characteristics